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Abstract
Management of ventricular septal defect (VSD) with severe pulmonary hypertension (PH) had not 
been extensively studied and is still challenging. The closure of VSD in patients with high pulmonary 
vascular resistance (PVR) and severe PH is highly risk procedure. If high PVR and severe PH 
still persist after closure procedure, the patients have poor prognosis. We reported a 24-year-old 
woman whom was diagnosed with large VSD, bidirectional shunt with L to R dominance, dilatation 
of left ventricle, and mild to moderate mitral regurgitation, mild tricuspid regurgitation and severe 
PH. Right heart catheterization showed pre-oxygen test: mean aorta pressure 85 mmHg, mean 
pulmonary artery pressure 65 mmHg, fl ow ratio 5,4, PVR 2,3 WU and pulmonary vascular resistance 
index (PVRI) 3,22 WU/m2. The results of post-oxygen test: mean aorta pressure 83 mmHg, 
mean pulmonary artery pressure 63 mmHg, fl ow Ratio 2,2, PVR 0,3 WU and PVRI 0,42 WU/m2. 
Patient had been performed VSD closure with perforated patch 3 mm. Three month evaluation by 
echocardiography showed residual VSD 3 mm, L to R shunt, moderate tricuspid regurgitation and 
mild PH (TVG 36 mmHg). In Baumgartner criteria of VSD operability, this patient was not operable 
because the ratio of mean pulmonary and systemic circulation more than 2/3, but in Lopez criteria, 
patient is operable because PVRI below 6 WU/m2. Patient with high and moderate PH and PVR 
which is still operable, VSD can be closed partially. Partially VSD closure can be performed by 
transcatheter procedure after PH decrease and stable.
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Background
The management of ventricular septal defect 
(VSD) with severe pulmonary hypertension (PH) 
had not yet extensively investigated.1 The closure 
procedure in VSD patients with increasing pulmonary 
vascular resistance (PVR) with severe PH is a 
risky procedure. The persistence of high PVR and 
severe PH after the closure procedure is the sign of 
a bad prognosis.1  In a restropective study, patient 
with congenital heart disease and severe PH post 
operatively had worse prognosis than patient with 
non-operative congenital heart disease.2 In this case 
we present and discuss a patient with large VSD, 
severe PH and non reactive oxygen test in whom 
the VSD closure was performed.
Case 
A woman 24 years old came to our hospital 
with a chief complaint of dyspnea. She felt dyspnea 
on effort since 10 months before admission, there 
was neither orthopnea nor paroxysmal nocturnal 
dyspnea. Patient had been diagnosed as large 
VSD since April 2014 and has been planned to 
have VSD closure.
Her physical examination demonstrated 
a good general condition and compos mentis. 
Blood pressure was 100/60 mmHg, heart rate 
was 82 bpm, respiratory rate was 22 x/minute, 
temperature was 36,5⁰C and peripheral oxygen 
saturation was 97%. No increased jugular venous 
pressure. Lung examination was normal. There 
was cardiomegaly with ictus cordis at intercostal 
space V left mid clavicula line.  In auscultation, S1 
was normal and S2 was louder, with holosystolic 
murmur grade 3/6 with punctum maximum at 
intercostal space III-IV left parasternal border. 
Abdominal and extremity examination were 
normal
Laboratory results showed hemoglobin 13,1 
g/dL, hematokrit 39%, leukocytes 7,94 x 10 3/μL, 
segment 59,6 %, limphocytes 31,6 %, monocytes 
6,9%, eosinophil 1,8%, basophil 0,1%. Blood 
chemistry showed BUN 11 mg/dL, creatinine 0,89 
mg/dL, SGOT 21 U/L, SGPT 18 U/L,  natrium 
138 mEq/L, potassium 3,8 mEq/L, and chloride 
102 mEq/L. An electrocardiography examination 
showed sinus rhythm, heart rate 76 bpm and 
normoaxis (fi gure 1).
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Chest X-ray examination in showed 
cardiomegaly (CTR > 0,5) and a protuding of 
pulmonary segment indicating the presence of 
pulmonary hypertension (fi gure 2).
Echocardiography examination results 
showed a large VSD with diameter 17-20 mm, 
bidirectional shunt with L-to-R shunt dominance, 
dilatation of left ventricle with LV diameter 55 
mm, ejection fraction 70%, diastolic dysfunction 
Figure 1. Electrocardiogram showed sinus rhtythm, heart rate 76 bpm and normoaxis
Figure 2. Cardiomegaly with CTR > 0,5 and protruding 
pulmonary segment
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relaxation type, normal right ventricle function, 
mild to moderate mitral regurgitaion, mild tricuspid 
regurgitation and severe PH (TVG was 74 mmHg). 
Right heart catheterization results showed: pre-
oxygen test mean aorta pressure was 85 mmHg, 
mean pulmonary artery pressure was 65 mmHg, 
fl ow ratio was 5,4, PVR was 2,3 WU and PVRI 
was 3,22 WU/m2. Post oxygen test:  mean aorta 
pressure was 83 mmHg, mean pulmonary artery 
pressure was 63 mmHg, fl ow ratio was 22, PVR 
was 0,3 WU and PVRI was 0,42 WU/m2. 
The patient had been done VSD closure in 
February 2015 with perforated patch 3 mm. The 
evaluation by echocardiography done in April 2015 
showed residual VSD with 3 mm diameter, L to R 
shunt, normal cardiac chambers, ejection fraction 
63%, uncoordinated motion, normal diastolic 
LV function and normal right ventricle function, 
moderate tricuspid regurgitation and mild PH (TVG 
36 mmHg) (fi gure 3). The patient was hospitalized 
within 8 days and discharge in stable condition. 
The peripheral oxigen saturation was 97%. The 
medication was sildenafi l 3 x 20 mg.
Discussion
Pulmonary hypertension can occur in 
congenital heart disease because of increasing 
pulmonary blood fl ow due to L-to-R shunt through 
the defect. An L-to-R shunt will increase arterial 
pulmonary pressure and cause a stress to the 
vessel wall, circumferential dilatation of wall 
vessel and endotelial dysfunction.3 There is a 
changing expression of vasoactive mediator such 
as endothelin-1, prostacyclin and nitrit oxide. 
Pulmonary vasoconstriction will occur and persist. 
The increased expression of vascular endothelin-1 
and fi broblast growth factors cause remodeling 
(hypertrophy and proliferation) of vascular smooth 
muscle cells and increasing of intracellular matrix 
deposition. This remodelling will cause increasing 
of PVR and subsequent right ventricle pressure.3 
Patient with moderate to large size 
congenital heart defect can suffers from PH but 
not pulmonary vascular disease (PVD) because 
there is no extensive and permanent remodeling 
in pulmonary vessel walls. Patient with severe 
PH and high pulmonary fl ow and normal PVR, 
may be considered to have VSD closure because 
the lesion in vessel walls is not yet extensive 
and may still be reversible. High PVR indicated 
that such patients have suffered from extensive 
and irreversible PVD.4 The closure of VSD in 
patient with moderate to large congenital defect, 
L to R shunt and moderate to high PVR is very 
high risk procedure because the extent of lesion 
in pulmonary vessels is unknown and there is 
no guarantee for good long term outcome.4 If 
PVR is still high in post operation, the patient’s 
prognosis is worse.4 A study in England reported 
that children whom suffered from severe PH post 
operatively had worse prognosis than patients with 
Eisenmenger syndrome.2 
When the right heart catheterization was 
done, a vasoreactive test was usually performed. 
The gold standard of vasoreactivity test was using 
inhaled nitric oxide (iNO) not only oxygen.5 In iNOP 
test 1 (inhaled nitric oxide as a preoperative test 
1) study showed that by using oxygen and iNOP 
(100% oxygen and 80 ppm iNOP) gave 97% and 
90% sensitivity and accuracy, respectively, to 
predict the operability in patient with congenital 
heart disease and PH, whereas oxygen only 
(100% oxygen) gave 64% sensitivity and 68% 
accuracy.6 
Currently, there is no consensus about 
hemodynamic criteria to determine operability in 
Figure 3. Echocardiogram in post-operation showed residual VSD 3 mm, L to R shunt
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congenital heart disease.7 There is a retrospective 
study showed that 38 patients with VSD and severe 
PH and high PVR (>6 WU) was closed, resulting in 8 
patients died because of severe PH post operation 
and 30 patients (79%) had good outcome post 
operation.8  It showed that PVR treshold in operable 
patient must be determined precisely, if the treshold 
too low it will exclude many patients whom actually 
may still be operable.8 Baumgartner et al. (2009)9 
give operability hemodinamic criteria in VSD with 
PH according to European Society of Cardiology 
guideline, which is as follows: 
Lopes et al. (2009) suggested a hemodynamic 
criteria for assessment of operability in patients 
with congenital heart disease and pulmonary 
artery hypertension. Table 2 showed the criteria 
suggested by Lopes et al. (2009).10 
Patients with high and moderate PH and 
PVR which is still operable in the criteria by Lopes 
et al. (2009)10, VSD can be closed partially, so 
if severe PH still persist post-operatively, right 
ventricle can be decompressed.11 According to 
Beghetti (2012) and Myers (2014),  partially VSD 
closure can be closed by transcatheter procedure 
after PH decrease and stable.4,7
In this case, the patient had been performed 
partially VSD closure, by making 3-3,5 mm hole in 
the patch, so it allows right ventricle to decompress 
if PH still persist post operation. Subsequently, 
this residual VSD can be closed by transcatether 
procedure. There are several case reports about 
transcatheter closure in patient that had residual 
VSD closure, such as by  Ramakrhrisnan et al. 
(2011)12 who reported residual VSD closure by 
Table 1. Hemodynamic criteria in the operability of VSD9 
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ADO II in baby and Catfi eld et al. (2005)13  who 
reported transcatheter VSD closure in VSD patient 
post operatively with patch dehisence.
Conclusion
We reported a 24-year-old woman large VSD 
and severe PH. The patient had been done VSD 
closure with perforated patch 3-3,5 mm. In post 
operative echocardiogram showed residual VSD 3 
mm, L to R shunt with improvement of PH from 79 
mmHg to 36 mmHg. A VSD closure in this patient 
was performed by perforated patch, to anticipate 
if PH persist post operatively, and be closed by 
transcatheter procedure if PH improve and stable 
in the follow up.
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